Abstract
Despite advances in diagnosis, antimicrobial therapy and supportive care modalities, community-acquired pneumonia (CAP) remains an important cause of morbidity and mortality, especially in patients who require hospitalization. Elderly patients with poor functional status are characterized by a higher risk of developing severe CAP, due to the frequent presence of underlying respiratory and cardiac diseases, alteration of mental status, and immunosuppression. In recent years, changes in the healthcare system have shifted a considerable part of older patient care from hospitals to the community, and the traditional distinction between community- and hospital-acquired infections has become less clear. Pneumonia occurring among outpatients in contact with the healthcare system has been termed healthcare-associated pneumonia. Older frail patients have a high frequency of aspiration pneumonia and pneumonia due to gram-negative bacilli and other multidrug resistant pathogens. The contemporary presence of renal impairment usually requires specific dose adjustment of antibiotic therapy, which may be toxic in this specific patient population. This review produces a summary of therapeutic recommendations on the basis of the most updated clinical and pharmacological data.
Similar content being viewed by others
References
Bartlett JG, Mundy LM (1995) Community-acquired pneumonia. N Engl J Med 24:1618–1624
Mandell LA, Bartlett JG, Dowel SF et al (2003) Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults. Clin Infect Dis 37:1405–1433
Houston MS, Silverstein MD, Suman VJ (1995) Community-acquired lower respiratory tract infection in the elderly: a community-based study of incidence and outcome. J Am Board Fam Pract 8(5):347–356
Fry A, Shay D, Holman R, Curns A, Anderson L (2005) Trends in hospitalizations for pneumonia among persons aged 65 years or older in the United States, 1998–2002. JAMA 294:2712–2719
Jackson ML, Neuzil KM, Thompson WW et al (2004) The burden of community acquired pneumonia in seniors: results of a population-based study. Clin Infect Dis 39:1642–1650
Jokinen C, Heiskanen L, Juvonen H et al (1993) Incidence of community-acquired pneumonia in the population of four municipalities in Eastern Europe. Am J Epidemiol 137:977–988
Kaplan V, Angus DC, Griffin MF et al (2002) Hospitalized community-acquired pneumonia in the elderly: age- and sex-related patterns of care and outcome in the United States. Am J Respir Crit Care Med 165:766–772
American Thoracic Society, Infectious Diseases Society of America (2005) Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 171:388–416
Muder RR, Aghababian RV, Loeb MB, Solot JA, Higbee M (2004) Nursing home-acquired pneumonia: an emergency department treatment algorithm. Curr Med Res Opin 20:1309–1320
Merli M, Lucidi C, Giannelli V et al (2010) Cirrhotic patients are at risk for health care-associated bacterial infections. Clin Gastroenterol Hepatol 8:979–985
Venditti M, Falcone M, Corrao S, Licata G, Study Group of the Italian Society of Internal Medicine (2009) Outcomes of patients hospitalized with community-acquired, healthcare-associated, and hospital-acquired pneumonia. Ann Intern Med 6(150):19–26
Falcone M, Venditti M, Corrao S, Society of Internal Medicine (SIMI) Study Group (2011) Italian role of multidrug-resistant pathogens in health-care-associated pneumonia. Lancet Infect Dis 11:11–12
Trotter CL, Stuart JM, George R, Miller E (2008) Increasing hospital admissions of pneumonia. England. Emerg Infect Dis 14:727–733
Feldman C (1999) Pneumonia in the elderly. Clin Chest Med 20:563–573
Marrie TJ (2000) Community-acquired pneumonia in the elderly. Clin Infect Dis 31:1066–1078
Loeb M (2003) Pneumonia in older persons. Clin Infect Dis 37:1335–1339
Niederman MS, McCombs JS, Unger AN et al (1998) The cost of treating community-acquired pneumonia. Clin Therapeut 20:820–837
Kahn JM, Benson NM, Appleby D et al (2010) Long-term acute care hospital utilization after critical illness. JAMA 303:2253–2259
Knickman JR, Snell EK (2002) The 2030 problem: caring for aging baby boomers. Health Serv Res 37(4):849–884
Mehr DR, Binder EF, Kruse RL et al (2001) Predicting mortality in nursing home residents with lower respiratory tract infection: the Missouri LRI Study. JAMA 286(19):2427–2436
Campbell AJ, Buchner DM (1997) Unstable disability and the fluctuations of frailty. Age Ageing 26:315–318
Buchner DM, Wagner EH (1992) Preventing frail health. Clin Geriatr Med 8:1–17
Bortz WM II (1993) The physics of frailty. J Am Geriatr Soc 41:1004–1008
Lipsitz LA, Goldberger AL (1992) Loss of “complexity” and aging: potential applications of fractals and chaos theory to senescence. JAMA 267:1806–1809
Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW (1963) Studies of illness in the aged: the Index of ADL: a standardized measure of biological and psychosocial function. JAMA 185:94–919
Fried LP, Tangen CM, Walston J et al (2001) Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 56(3):M146–M156
Woods GL, Isaacs RD, McCarroll KA, Friedland IR (2003) Ertapenem therapy for community-acquired pneumonia in the elderly. J Am Geriatr Soc 51:1526–1532
Venkatesan P, Gladman J, Macfarlane JT et al (1990) A hospital study of community acquired pneumonia in the elderly. Thorax 45:254–258
Saito A, Kohno S, Matsushima T, for the Study Group et al (2006) Prospective multicenter study of the causative organisms of community-acquired pneumonia in adults in Japan. J Infect Chemother 12:63–69
Mandell LA (2009) Severe community-acquired pneumonia (CAP) and the Infectious Diseases Society of America/American Thoracic Society CAP guidelines prediction rule: validated or not. Clin Infect Dis 48(4):386–388
Falcone M, Serra P, Venditti M (2009) Serious infections due to methicillin-resistant Staphylococcus aureus: an evolving challenge for physicians. Eur J Intern Med 20:343–347
El-Solh AA, Pietrantoni C, Bhat A (2003) Microbiology of severe aspiration pneumonia in institutionalized elderly. Am J Respir Crit Care Med 167(12):1650–1654
Naimi TS, LeDell KH, Como-Sabetti K et al (2003) Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA 290:2976–2984
Huang SS, Hinrichsen VL, Stulgis L et al (2006) Methicillin-resistant Staphylococcus aureus infection in the year following detection of carriage (abstract 157). In: Program and abstracts of the Society of Healthcare Epidemiology of America Annual Meeting (Chicago), Arlington, VA: Society for Healthcare Epidemiology of America
Friedmann R, Raveh D, Zartzer E et al (2009) Prospective evaluation of colonization with extended-spectrum beta-lactamase (ESBL)-producing enterobacteriaceae among patients at hospital admission and of subsequent colonization with ESBL-producing enterobacteriaceae among patients during hospitalization. Infect Control Hosp Epidemiol 30:534–542
Zahar JR, Lanternier F, Mechai F et al (2010) Duration of colonisation by enterobacteriaceae producing extended-spectrum beta-lactamase and risk factors for persistent faecal carriage. J Hosp Infect 75:76–78
Pop-Vicas A, Mitchell SL, Kandel R, Schreiber R, D’Agata EM (2008) Multidrug-resistant gram-negative bacteria in a long-term care facility: prevalence and risk factors. J Am Geriatr Soc 56:1276–1280
Riquelme R, Torres A, Wl-Ebiary M et al (1997) Community-acquired pneumonia in the elderly. Am J Respir Crit Care Med 156:1908–1914
High KP, Bradley SF, Gravenstein S et al (2009) Clinical practice guideline for the evaluation of fever and infection in older adult residents of long-term care facilities: 2008 update by the Infectious Diseases Society of America. Clin Infect Dis 48(2):149–171
Mandell LA, Wunderink RG, Anzueto A et al (2007) Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 44(Suppl 2):S27–S72
Fernandez-Sabe N, Carratala J, Roso NB et al (2003) Community-acquired pneumonia in very elderly patients: causative organisms, clinical characteristics, and outcomes. Medicine (Baltimore) 82:159–169
Quagliarello V, Ginter S, Han L et al (2005) Modifiable risk factors for nursing home-acquired pneumonia. Clin Infect Dis 40:1–6
Teramoto S, Fukuchi Y, Sasaki H et al (2008) High incidence of aspiration pneumonia in community and hospital-acquired pneumonia in hospitalized patients: a multicenter, prospective study in Japan. J Am Geriatr Soc 56:577–579
Fine MJ, Auble TE, Yealy DM et al (1997) Prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 336:243–250
Falcone M, Corrao S, Venditti M, Serra P, Licata G (2011) Performance of PSI, CURB-65, and SCAP scores in predicting the outcome of patients with community-acquired and healthcare-associated pneumonia. Intern Emerg Med 6:431–436
Garcia-Vidal C, Fernandez-Sabe N, Carratala J et al (2008) Early mortality in patients with community-acquired pneumonia: causes and risk factors. Eur Respir J 32:733–739
Charles PG, Wolfe R, Whitby M et al (2008) SMART-COP: a tool for predicting the need for intensive respiratory or vasopressor support in community-acquired pneumonia. Clin Infect Dis 47:375–384
Cabre M, Serra-Prat M, Force L et al (2008) Functional status as a risk factor for mortality in very elderly patients with pneumonia. Med Clin (Barc) 131:167–170
Kothe H, Bauer T, Marre R et al (2008) Competence network for community-acquired pneumonia study group. Outcome of community-acquired pneumonia: influence of age, residence status and antimicrobial treatment. Eur Respir J 32:139–146
Mortensen EM, Coley CM, Singer DE et al (2002) Causes of death for patients with community-acquired pneumonia: results from the Pneumonia Patient Outcomes Research Team cohort study. Arch Intern Med 162:1059–1064
Falcone M, Shindo Y, Venditti M, Kollef MH (2011) Healthcare-associated pneumonia: diagnostic criteria and distinction from community-acquired pneumonia. Int J Infect Dis 15:e545–e550
Micek ST, Reichley RM, Kollef MH (2011) Health care-associated pneumonia (HCAP): empiric antibiotics targeting methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa predict optimal outcome. Medicine (Baltimore) 90:390–395
Kollef MH, Micek ST (2012) Patients hospitalized with pneumonia: determining the need for broad-spectrum antibiotic therapy. Clin Infect Dis 54:479–482
Aliberti S, Di Pasquale M, Zanaboni AM, Cosentini R, Brambilla AM, Seghezzi S, Tarsia P, Mantero M, Blasi F (2011) Stratifying risk factors for multidrug-resistant pathogens in hospitalized patients coming from the community with pneumonia. Clin Infect Dis
Shorr AF, Zilberberg MD, Reichley R et al (2012) Validation of a clinical score for assessing the risk of resistant pathogens in patients with pneumonia presenting to the emergency department. Clin Infect Dis 54(2):193–198
Stein GE, Wells EM (2010) The importance of tissue penetration in achieving successful antimicrobial treatment of nosocomial pneumonia and complicated skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus: vancomycin and linezolid. Curr Med Res Opin 26:571–588
Wunderink RG, Niederman MS, Kollef MH et al (2012) Linezolid in methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a randomized controlled study. Clin Infect Dis 54:621–629
Orsi GB, Falcone M, Venditti M (2011) Surveillance and management of multidrug-resistant microorganisms. Expert Rev Anti Infect Ther 9:653–679
Falcone M, Mezzatesta ML, Perilli M et al (2009) VIM-1 metallo-β-lactamase producing Enterobacter cloacae infections and their correlation with clinical outcome. J Clin Microbiol 47:3514–3519
Orsi GB, Garcia-Fernandez A, Giordano A et al (2011) Risk factors for and clinical significance of ertapenem-resistant Klebsiella pneumoniae in hospitalised patients. J Hosp Infect 78:54–58
Kristoffersen KB, Sogaard OS, Wejse C, Black FT, Greve T, Tarp B et al (2009) Antibiotic treatment interruption of suspected lower respiratory tract infections based on a single procalcitonin measurement at hospital admission—a randomized trial. Clin Microbiol Infect 15:481–487
Acknowledgments
The authors have been served as members of an advisory board on infections in Internal Medicine funded by an unrestricted grant by Pfizer.
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Falcone, M., Blasi, F., Menichetti, F. et al. Pneumonia in frail older patients: an up to date. Intern Emerg Med 7, 415–424 (2012). https://doi.org/10.1007/s11739-012-0796-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11739-012-0796-7